Immuron IMRN
NASDAQ IMRN
$1.24 +0.02 (+1.64%)
At close: Sep 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Income towards Parent Company (2016 - 2025)

Immuron (IMRN) posted Income towards Parent Company of -$3.3 million for Q2 2025, down 7126.84% on a QoQ basis from -$46223.4 in Q3 2024, and up 26.93% year-over-year from -$2.6 million in Q2 2024.

Analysis

Immuron (IMRN) Income towards Parent Company (2016 - 2025) Analysis & Trends

Immuron has reported Income towards Parent Company for 10 years, with the latest figure at -$3.3 million in Q2 2025.

  • On a quarterly basis, Income towards Parent Company rose 26.93% year-over-year to -$3.3 million in Q2 2025; TTM through Jun 2025 was -$8.0 million, a 29.02% decrease from a year earlier, with the FY2026 full-year figure at -$3.8 million, down 7207.34% from the prior year.
  • Income towards Parent Company was -$3.3 million for Q2 2025 at Immuron, down from -$46223.4 in the prior quarter.
  • The five-year high for Income towards Parent Company was -$13260.2 in Q4 2021, with the low at -$6.5 million in Q2 2021.
  • Average Income towards Parent Company over 5 years is -$2.0 million, with a median of -$795595.5 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Income towards Parent Company slumped 2558.11% in 2022, then jumped 93.01% in 2023.
  • Over 5 years, Income towards Parent Company stood at -$13260.2 in 2021, then plunged by 2558.11% to -$352470.5 in 2022, then surged by 93.01% to -$24649.8 in 2023, then tumbled by 87.52% to -$46223.4 in 2024, then plunged by 7126.84% to -$3.3 million in 2025.
  • The last three Income towards Parent Company figures came in at -$3.3 million (Q2 2025), -$46223.4 (Q3 2024), and -$4.6 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Immuron 7.14 Mn -1.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.34 Mn
Sep 9, 2024 -46,223.37
Jun 30, 2024 -4.57 Mn
Dec 31, 2023 -24,649.80
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -352,470.52
Dec 31, 2021 -13,260.17
Jun 30, 2021 -6.46 Mn
Dec 31, 2020 -41,946.68
Jun 30, 2020 -1.92 Mn
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.79 Mn
Dec 31, 2016 2.57 Mn
Jun 30, 2016 -3.28 Mn
API Access

Immuron Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=IMRN&period=max&api_key=YOUR_API_KEY